Osteoporosis is a systemic skeletal disease associated with reduced bone strong point that results in raised fracture risk, with decreased bone strength, leading to reduced bone mineral density and poor bone quality. It is the most common in older females but some men are also at high risk. Although considered as a predictable result of aging, it is can be avoidable and treatable.
Source: Science Daily
Scientists have discovered a new protein complex that keeps the brakes on stem cells, allowing them to maintain their indefinite potential. The new complex, called GBAF, could provide a future target for regenerative medicine.
Though very few of these applications have any scientific backing, stem cell therapy for knees has been the subject of quite a few promising studies.
Many studies of autologous hematopoietic stem cell transplantation (HSCT) and allogeneic HSCT have been conducted for autoimmune disease in various animal models.
Source: MED Stanford
Identification of the human skeletal stem cell by Stanford scientists could pave the way for regenerative treatments for bone fractures, arthritis and joint injuries.
Stem cell research began as a potential means of identifying new treatment options for intractable and lethal diseases. In the orthopaedic field, diseases in which current treatment methods are unsatisfactory, inefficient, or incapable of providing durable results are targets for stem cell therapy.
PRP or Platelet Rich Plasma has hit the mainstream media. PRP is a mix of concentrated platelets and serum. Why is this important? Surgeons have known for years that healing depends on platelets.